Since the UK Prospective Diabetes Study (UKPDS), it has been known that the progressive deterioration of insulin secretion over time leads to the failure of non-insulin therapies, necessitating insulin intensification in patients with T2DM (1) (Figure 1). Here, INS is linked to type 2 diabetes mellitus.